Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
NASDAQ:HBIO
Price:
0.5301
USD
9.07%
Market Cap:
$23.7m
Balance Sheet
Balance Sheet Decomposition
Harvard Bioscience Inc
Harvard Bioscience Inc
Balance Sheet Decomposition is not available for
Harvard Bioscience Inc
Harvard Bioscience Inc
Balance Sheet
Harvard Bioscience Inc
Harvard Bioscience Inc
Currency: USD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
29
|
15
|
8
|
14
|
8
|
9
|
18
|
14
|
17
|
20
|
18
|
21
|
26
|
14
|
7
|
6
|
5
|
8
|
8
|
8
|
8
|
5
|
4
|
4
|
|
| Cash Equivalents |
29
|
15
|
8
|
14
|
8
|
9
|
18
|
14
|
17
|
20
|
18
|
21
|
26
|
14
|
7
|
6
|
5
|
8
|
8
|
8
|
8
|
5
|
4
|
4
|
|
| Total Receivables |
8
|
14
|
20
|
19
|
10
|
13
|
15
|
15
|
17
|
18
|
18
|
19
|
18
|
21
|
21
|
20
|
17
|
25
|
23
|
21
|
26
|
20
|
20
|
15
|
|
| Accounts Receivables |
7
|
14
|
19
|
19
|
10
|
13
|
15
|
15
|
14
|
15
|
15
|
14
|
14
|
16
|
18
|
16
|
13
|
22
|
21
|
18
|
22
|
17
|
16
|
15
|
|
| Other Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
5
|
4
|
5
|
4
|
4
|
4
|
3
|
3
|
3
|
4
|
4
|
4
|
0
|
|
| Inventory |
6
|
16
|
25
|
26
|
9
|
11
|
15
|
12
|
14
|
16
|
18
|
18
|
16
|
21
|
22
|
20
|
17
|
25
|
22
|
22
|
28
|
26
|
25
|
23
|
|
| Other Current Assets |
2
|
3
|
3
|
4
|
28
|
20
|
7
|
3
|
1
|
5
|
4
|
2
|
2
|
2
|
0
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Current Assets |
45
|
48
|
56
|
61
|
55
|
53
|
54
|
44
|
48
|
59
|
58
|
59
|
61
|
57
|
51
|
46
|
48
|
58
|
54
|
52
|
62
|
51
|
49
|
45
|
|
| PP&E Net |
4
|
6
|
7
|
7
|
4
|
5
|
5
|
3
|
4
|
3
|
3
|
5
|
4
|
5
|
6
|
4
|
4
|
6
|
13
|
12
|
10
|
9
|
9
|
11
|
|
| PP&E Gross |
4
|
6
|
7
|
7
|
4
|
5
|
5
|
3
|
4
|
3
|
3
|
5
|
4
|
5
|
6
|
4
|
4
|
6
|
13
|
12
|
10
|
9
|
9
|
11
|
|
| Accumulated Depreciation |
2
|
3
|
5
|
7
|
5
|
7
|
9
|
8
|
9
|
10
|
10
|
13
|
14
|
15
|
16
|
15
|
16
|
17
|
15
|
17
|
14
|
15
|
14
|
16
|
|
| Intangible Assets |
0
|
20
|
28
|
27
|
11
|
11
|
12
|
10
|
22
|
23
|
24
|
23
|
20
|
22
|
22
|
19
|
11
|
46
|
38
|
33
|
27
|
21
|
16
|
11
|
|
| Goodwill |
33
|
31
|
36
|
43
|
21
|
24
|
28
|
24
|
32
|
33
|
34
|
36
|
37
|
40
|
40
|
38
|
36
|
57
|
57
|
59
|
58
|
56
|
57
|
56
|
|
| Other Long-Term Assets |
1
|
2
|
1
|
2
|
0
|
1
|
0
|
1
|
1
|
7
|
8
|
11
|
13
|
11
|
1
|
1
|
11
|
2
|
2
|
1
|
5
|
8
|
6
|
3
|
|
| Other Assets |
33
|
31
|
36
|
43
|
21
|
24
|
28
|
24
|
32
|
33
|
34
|
36
|
37
|
40
|
40
|
38
|
36
|
57
|
57
|
59
|
58
|
56
|
57
|
56
|
|
| Total Assets |
82
N/A
|
108
+31%
|
128
+19%
|
140
+9%
|
92
-35%
|
93
+2%
|
99
+6%
|
81
-18%
|
107
+32%
|
125
+16%
|
127
+1%
|
134
+5%
|
136
+1%
|
136
+0%
|
120
-12%
|
108
-10%
|
109
+1%
|
169
+54%
|
165
-2%
|
156
-5%
|
162
+4%
|
145
-10%
|
137
-6%
|
127
-8%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
3
|
6
|
7
|
6
|
3
|
5
|
6
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
9
|
6
|
4
|
7
|
5
|
6
|
5
|
6
|
6
|
5
|
|
| Accrued Liabilities |
3
|
7
|
5
|
5
|
3
|
4
|
4
|
4
|
4
|
5
|
3
|
4
|
5
|
5
|
4
|
5
|
4
|
6
|
2
|
8
|
11
|
9
|
9
|
8
|
|
| Short-Term Debt |
4
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
2
|
2
|
3
|
6
|
7
|
2
|
3
|
4
|
6
|
37
|
|
| Other Current Liabilities |
2
|
3
|
4
|
5
|
7
|
6
|
4
|
1
|
4
|
2
|
1
|
2
|
1
|
2
|
4
|
2
|
3
|
6
|
11
|
6
|
6
|
4
|
6
|
5
|
|
| Total Current Liabilities |
12
|
17
|
16
|
16
|
13
|
15
|
16
|
11
|
12
|
11
|
10
|
10
|
16
|
18
|
19
|
15
|
14
|
26
|
25
|
21
|
25
|
23
|
27
|
55
|
|
| Long-Term Debt |
1
|
0
|
13
|
17
|
9
|
3
|
6
|
0
|
13
|
18
|
16
|
13
|
20
|
17
|
16
|
11
|
9
|
55
|
47
|
46
|
45
|
43
|
31
|
0
|
|
| Deferred Income Tax |
3
|
1
|
0
|
2
|
1
|
1
|
2
|
1
|
2
|
1
|
0
|
0
|
0
|
1
|
4
|
6
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
1
|
1
|
1
|
1
|
2
|
1
|
2
|
4
|
4
|
5
|
6
|
5
|
5
|
3
|
3
|
3
|
3
|
9
|
10
|
7
|
6
|
6
|
8
|
|
| Total Liabilities |
16
N/A
|
19
+24%
|
30
+54%
|
36
+20%
|
23
-35%
|
21
-8%
|
25
+16%
|
15
-41%
|
32
+119%
|
35
+8%
|
31
-10%
|
29
-6%
|
41
+40%
|
40
-1%
|
43
+5%
|
36
-16%
|
29
-20%
|
86
+201%
|
83
-3%
|
80
-4%
|
79
-1%
|
73
-7%
|
64
-12%
|
63
-2%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Retained Earnings |
84
|
83
|
79
|
76
|
108
|
110
|
111
|
110
|
103
|
83
|
80
|
77
|
95
|
93
|
112
|
116
|
117
|
120
|
125
|
132
|
133
|
142
|
146
|
158
|
|
| Additional Paid In Capital |
152
|
171
|
172
|
174
|
174
|
176
|
179
|
182
|
185
|
188
|
191
|
197
|
202
|
207
|
212
|
215
|
219
|
226
|
229
|
232
|
226
|
229
|
232
|
237
|
|
| Treasury Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
6
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
5
|
8
|
3
|
6
|
7
|
3
|
2
|
4
|
6
|
5
|
3
|
8
|
12
|
17
|
11
|
14
|
13
|
13
|
10
|
15
|
14
|
16
|
|
| Total Equity |
67
N/A
|
88
+32%
|
99
+12%
|
104
+6%
|
68
-34%
|
72
+5%
|
74
+3%
|
67
-10%
|
75
+13%
|
90
+20%
|
96
+6%
|
104
+9%
|
95
-9%
|
96
+1%
|
78
-19%
|
72
-7%
|
81
+12%
|
83
+2%
|
82
-1%
|
77
-6%
|
83
+9%
|
72
-13%
|
73
+1%
|
63
-13%
|
|
| Total Liabilities & Equity |
82
N/A
|
108
+31%
|
128
+19%
|
140
+9%
|
92
-35%
|
93
+2%
|
99
+6%
|
81
-18%
|
107
+32%
|
125
+16%
|
127
+1%
|
134
+5%
|
136
+1%
|
136
+0%
|
120
-12%
|
108
-10%
|
109
+1%
|
169
+54%
|
165
-2%
|
156
-5%
|
162
+4%
|
145
-10%
|
137
-6%
|
127
-8%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
27
|
30
|
30
|
30
|
31
|
31
|
31
|
30
|
30
|
28
|
29
|
29
|
32
|
33
|
34
|
34
|
35
|
37
|
38
|
39
|
41
|
42
|
43
|
44
|
|
Switch to:
Switch to:
See Also
Discover More
